Top Stories Sarepta Stock Plummets After Refusing FDA Drug Withdrawal Request BREAKING: Sarepta Therapeutics is facing a steep decline in its stock prices after the company publicly refused a Food and Drug Administration (FDA) request... Editorial21 July, 2025